Yishen Huashi Granules Ameliorated the Development of Diabetic Nephropathy by Reducing the Damage of Glomerular Filtration Barrier
Background: Diabetic nephropathy (DN) is one of the most common complications of diabetes and the primary cause of end-stage renal disease. At present, renin–angiotensin–aldosterone system (RAAS) blockers have been applied as first-class drugs to restrain development of DN; however, its long-term ef...
Main Authors: | Tingting Zhao, Minyi Li, Qian Xiang, Beifeng Lie, Deqi Chen, Weiming Wang, Xuling Li, Tiancheng Xu, Xi Zhang, Yuntong Li, Ruixue Dong, Xinwen Du, Yilin Wang, Junzheng Yang, Bao He, Quan Zhu, Tingting Duan, Zhenghai Li, Youhua Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-07-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.872940/full |
Similar Items
-
Yishen Huashi granule modulated lipid metabolism in diabetic nephropathy via PI3K/AKT/mTOR signaling pathways
by: Tingting Zhao, et al.
Published: (2023-03-01) -
Efficacy and safety of Yishen Huashi granules combined with conventional therapy in the treatment of diabetic kidney disease: A systematic review and meta-analysis
by: Bo Dai, et al.
Published: (2024-10-01) -
Protective effect of Huashi Baidu formula against AKI and active ingredients that target SphK1 and PAI-1
by: Yute Zhong, et al.
Published: (2024-11-01) -
Sanhan Huashi Formula and Its Bioactive Compounds Exert Antiviral and Anti-Inflammatory Effects on COVID-19
by: Chuanxi Tian, et al.
Published: (2024-12-01) -
Network pharmacology and experimental validation to elucidate the pharmacological mechanisms of Bushen Huashi decoction against kidney stones
by: Haizhao Liu, et al.
Published: (2023-02-01)